KR20230161962A - 나이세리아 고노르호애의 치료 방법 및 재료 - Google Patents
나이세리아 고노르호애의 치료 방법 및 재료 Download PDFInfo
- Publication number
- KR20230161962A KR20230161962A KR1020237031684A KR20237031684A KR20230161962A KR 20230161962 A KR20230161962 A KR 20230161962A KR 1020237031684 A KR1020237031684 A KR 1020237031684A KR 20237031684 A KR20237031684 A KR 20237031684A KR 20230161962 A KR20230161962 A KR 20230161962A
- Authority
- KR
- South Korea
- Prior art keywords
- cycloheteroalkyl
- compound
- infection
- alkyl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166309P | 2021-03-26 | 2021-03-26 | |
| US63/166,309 | 2021-03-26 | ||
| PCT/US2022/021467 WO2022204231A2 (en) | 2021-03-26 | 2022-03-23 | Methods and materials for treatment of neisseria gonorrhoeae infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230161962A true KR20230161962A (ko) | 2023-11-28 |
Family
ID=83398108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237031684A Pending KR20230161962A (ko) | 2021-03-26 | 2022-03-23 | 나이세리아 고노르호애의 치료 방법 및 재료 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250339401A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313040A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511945A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230161962A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117396201A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022244356A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3211535A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022204231A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023150719A1 (en) * | 2022-02-03 | 2023-08-10 | Purdue Research Foundation | Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005500289A (ja) * | 2001-06-13 | 2005-01-06 | マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド | ラクトン処方物および使用方法 |
| BRPI0620157A2 (pt) * | 2005-12-15 | 2011-12-20 | Activbiotics Pharma Llc | usos de rifamicinas |
| US20210317099A1 (en) * | 2020-04-09 | 2021-10-14 | Purdue Research Foundation | Safer, potent, and fast acting antimicrobial agents |
-
2022
- 2022-03-23 CA CA3211535A patent/CA3211535A1/en active Pending
- 2022-03-23 KR KR1020237031684A patent/KR20230161962A/ko active Pending
- 2022-03-23 CN CN202280024693.0A patent/CN117396201A/zh active Pending
- 2022-03-23 JP JP2023555485A patent/JP2024511945A/ja active Pending
- 2022-03-23 US US18/550,288 patent/US20250339401A1/en active Pending
- 2022-03-23 AU AU2022244356A patent/AU2022244356A1/en active Pending
- 2022-03-23 EP EP22776535.1A patent/EP4313040A4/en active Pending
- 2022-03-23 WO PCT/US2022/021467 patent/WO2022204231A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022204231A3 (en) | 2022-12-29 |
| CA3211535A1 (en) | 2022-09-29 |
| CN117396201A (zh) | 2024-01-12 |
| WO2022204231A2 (en) | 2022-09-29 |
| US20250339401A1 (en) | 2025-11-06 |
| EP4313040A2 (en) | 2024-02-07 |
| AU2022244356A1 (en) | 2023-09-28 |
| EP4313040A4 (en) | 2025-02-12 |
| JP2024511945A (ja) | 2024-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210317099A1 (en) | Safer, potent, and fast acting antimicrobial agents | |
| CN1416428A (zh) | 具有抗肿瘤活性的化合物、其制备方法以及含有该化合物的药物组合物 | |
| CN109923110A (zh) | 苔藓抑素化合物和其制备方法 | |
| US20220226284A1 (en) | Methods for the treatment of mycobacterium infections | |
| KR20180108675A (ko) | 브로모도메인 억제제인 카르볼린 유도체 | |
| CN116283939B (zh) | 一种具有光响应活性的抗真菌化合物及其应用 | |
| US20250339401A1 (en) | Methods and materials for treatment of neisseria gonorrhoeae infection | |
| FR2801310A1 (fr) | NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT | |
| KR102650441B1 (ko) | 내부 사이클릭 설피아미딘 아미드-아릴 아미드 화합물 및 이의 b형 간염 치료를 위한 용도 | |
| CN118406042B (zh) | 含吡啶环的两亲性蛇床子素-季铵盐杂合体及其制备方法和抗菌应用 | |
| US7250438B2 (en) | Anti-bacterial and anti-cancer spiro beta-lactone/gamma-lactams | |
| US8653283B2 (en) | Anticancer agents | |
| JP4769726B2 (ja) | コンセントリコリド及びその誘導体、それらを調製する工程、それを含む薬学的組成物並びにその使用 | |
| Diwakar et al. | Synthesis, X-ray characterization and biological evaluation of some new 2-(4-methy-2-oxo-2 H-chromen-7yloxy) acetamide derivatives | |
| CN112851561A (zh) | 一种nr6a1蛋白受体抑制剂及其制备和应用 | |
| US20060111420A1 (en) | Sorbicillactone-a derivatives for the treatment of tumour and viral diseases | |
| JP2002535276A (ja) | 4−デメチルペンクロメジンのアシル誘導体、その使用及び調製 | |
| US20250195490A1 (en) | Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi) | |
| CN113387808B (zh) | Tagalsin C二萜衍生物及其制备和用途 | |
| CN114507139B (zh) | 环丙烷类化合物及其制备方法与抗流感病毒的应用 | |
| CN115141204B (zh) | 一种萘[1,2-b]呋喃-4,5-二酮衍生物其制备及其用途 | |
| Baker et al. | Methods for the treatment of Mycobacterium infections | |
| Chang et al. | Synthesis, Anticancer Evaluation and Structure–Activity Relationship of Taiwanin a Derivatives | |
| JP6359409B2 (ja) | トール様受容体4活性化作用を有するフニクロシン誘導体及びその用途 | |
| Shinonaga et al. | 13-Bromomonocillin I: a new WNT-5A expression inhibitor produced by Pochonia chlamydosporia var. chlamydosporia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20230915 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20250313 Comment text: Request for Examination of Application |